[Verified Answer]: Mrs

Mrs. George is a 66-year-old woman with T2D and chronic kidney disease (CKD stage 3A). Today her A1C is 8.0% and her estimated glomerular filtration rate (eGFR is) 56 mL/min, both of which are relatively unchanged from 6 months ago. She continues to take metformin 1000 mg twice daily, losartan 100 mg daily, and atorvastatin 20 mg at night. According to the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in CKD, which of the following action steps would be most important to consider at this time? A. Start a GLP-1 RA proven to improve kidney outcomes B. Start a sodium-glucose co-transporter 2 (SGLT2) inhibitor with primary evidence for kidney benefit C. Increase her losartan dose D. Augment her atorvastatin to high-intensity